Tsveta Milanova Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

Tsveta Milanova is Chief Commercial Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 34,793 shares of AGIO, which is worth approximately $1.52 Million. The most recent transaction as insider was on Jan 05, 2026, when has been sold 2,872 shares (Common Stock) at a price of $27.02 per share, resulting in proceeds of $77,601. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.8K

33.19% 3M change

84.03% 12M change

Total Value Held $1.52 Million

Tsveta Milanova Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2026	SELL Open market or private sale	$77,601 $27.02 p/Share	2,872 Reduced 7.63%	34,793 Common Stock
Jan 05 2026	BUY Exercise of conversion of derivative security	-	8,475 Added 18.37%	37,665 Common Stock
Dec 30 2025	SELL Open market or private sale	$79,427 $27.09 p/Share	2,932 Reduced 9.13%	29,190 Common Stock
Dec 30 2025	BUY Exercise of conversion of derivative security	-	6,000 Added 15.74%	32,122 Common Stock
Jun 24 2025	SELL Open market or private sale	$92,905 $33.54 p/Share	2,770 Reduced 9.59%	26,122 Common Stock
Jun 24 2025	BUY Exercise of conversion of derivative security	-	6,000 Added 17.2%	28,892 Common Stock
Mar 03 2025	SELL Open market or private sale	$59,742 $35.54 p/Share	1,681 Reduced 6.84%	22,892 Common Stock

Mar 01 2025	BUY Exercise of conversion of derivative security	-	5,667 Added 18.74%	24,573 Common Stock
Jan 06 2025	SELL Open market or private sale	$90,232 $32.18 p/Share	2,804 Reduced 12.92%	18,906 Common Stock
Jan 03 2025	BUY Exercise of conversion of derivative security	-	8,476 Added 28.08%	21,710 Common Stock
Jan 24 2024	SELL Open market or private sale	$35,013 $21.64 p/Share	1,618 Reduced 10.89%	13,234 Common Stock
Jan 20 2024	BUY Exercise of conversion of derivative security	-	5,448 Added 26.84%	14,852 Common Stock
Jan 05 2024	SELL Open market or private sale	$64,772 $22.32 p/Share	2,902 Reduced 23.58%	9,404 Common Stock
Jan 03 2024	BUY Exercise of conversion of derivative security	-	8,475 Added 40.78%	12,306 Common Stock
Jun 30 2023	SELL Open market or private sale	$45,886 $28.36 p/Share	1,618 Reduced 29.69%	3,831 Common Stock
Jun 28 2023	BUY Exercise of conversion of derivative security	-	5,449 Added 50.0%	5,449 Common Stock

Tsveta Milanova

Chief Commercial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Value

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO

Account